Diana DeGette actually said...
under this Drug Safety Enhancement Act which Mr. Dingell and some of us introduced yesterday, would that give the FDA new authorities to address issues like intentional economic adulteration like in the heparin situation?
Context
DeGette questions the effectiveness of the Drug Safety Enhancement Act regarding FDA authorities.
04/12/2011